ATE292466T1 - Neue zusammensetzung auf basis von einem thiazolidindion und metformin und verwendung - Google Patents

Neue zusammensetzung auf basis von einem thiazolidindion und metformin und verwendung

Info

Publication number: ATE292466T1
Authority: AT; Austria
Prior art keywords: thiazolidindione; metformin; composition based; new composition; new
Prior art date: 1999-11-16

Application number

AT00976156T

Other languages

English (en)

Inventor

Karen Lewis

Nicola Jayne Lilliott

Donald C Mackenzie

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-16

Filing date

2000-11-16

Publication date

2005-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27447849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE292466(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-16 Priority claimed from GBGB9927119.9A external-priority patent/GB9927119D0/en

1999-11-16 Priority claimed from GBGB9927120.7A external-priority patent/GB9927120D0/en

2000-05-31 Priority claimed from GB0013240A external-priority patent/GB0013240D0/en

2000-05-31 Priority claimed from GB0013236A external-priority patent/GB0013236D0/en

2000-11-16 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2005-04-15 Application granted granted Critical

2005-04-15 Publication of ATE292466T1 publication Critical patent/ATE292466T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT00976156T 1999-11-16 2000-11-16 Neue zusammensetzung auf basis von einem thiazolidindion und metformin und verwendung ATE292466T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9927119.9A GB9927119D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GBGB9927120.7A GB9927120D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GB0013240A GB0013240D0 (en)	2000-05-31	2000-05-31	Novel composition and use
GB0013236A GB0013236D0 (en)	2000-05-31	2000-05-31	Novel composition and use
PCT/GB2000/004368 WO2001035941A2 (en)	1999-11-16	2000-11-16	Novel composition based on a thiazolidinedione and metformin and use

Publications (1)

Publication Number	Publication Date
ATE292466T1 true ATE292466T1 (de)	2005-04-15

Family

ID=27447849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00976156T ATE292466T1 (de)	1999-11-16	2000-11-16	Neue zusammensetzung auf basis von einem thiazolidindion und metformin und verwendung

Country Status (40)

Country	Link
US (1)	US8236345B2 (de)
EP (3)	EP1231918B1 (de)
JP (2)	JP4865975B2 (de)
KR (1)	KR100760063B1 (de)
CN (1)	CN1222290C (de)
AP (1)	AP1389A (de)
AR (2)	AR030920A1 (de)
AT (1)	ATE292466T1 (de)
AU (3)	AU775654B2 (de)
BG (1)	BG65616B1 (de)
BR (1)	BR0015605A (de)
CA (1)	CA2388846A1 (de)
CO (1)	CO5300392A1 (de)
CZ (1)	CZ302500B6 (de)
DE (1)	DE60019329T2 (de)
DK (1)	DK1231918T3 (de)
DZ (1)	DZ3251A1 (de)
EA (1)	EA004878B1 (de)
ES (1)	ES2240199T3 (de)
HK (1)	HK1049788B (de)
HR (1)	HRP20020416B1 (de)
HU (1)	HU229960B1 (de)
IL (3)	IL149618A0 (de)
MA (1)	MA25567A1 (de)
ME (1)	ME00318B (de)
MX (1)	MXPA02005005A (de)
MY (1)	MY125516A (de)
NO (1)	NO329926B1 (de)
NZ (1)	NZ518946A (de)
OA (1)	OA12513A (de)
PE (1)	PE20011011A1 (de)
PL (1)	PL200943B1 (de)
PT (1)	PT1231918E (de)
RS (1)	RS51343B (de)
SI (1)	SI1231918T1 (de)
SK (1)	SK286985B6 (de)
TW (1)	TWI240626B (de)
UA (1)	UA73150C2 (de)
UY (1)	UY26439A1 (de)
WO (1)	WO2001035941A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1278513B1 (de) *	2000-05-01	2007-07-18	Aeropharm Technology, LLC	Kernformulierung
EP1429740A4 (de) *	2001-07-10	2005-01-26	Kos Life Sciences Inc	Kernformulierung mit troglitazon und einem biguanid
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
AU2002356419A1 (en) *	2002-06-17	2003-12-31	Themis Laboratories Private Limited	Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
WO2004006921A1 (ja) *	2002-07-11	2004-01-22	Takeda Pharmaceutical Company Limited	被覆製剤の製造法
US8637512B2 (en) *	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP1539144B1 (de) *	2002-09-20	2014-12-24	Andrx Labs Llc	Mehrstufige formulierung mit einem biguanid und einem thiazolidindion-derivat
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
UA80991C2 (en) *	2002-10-07	2007-11-26		Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
MXPA05007883A (es)	2003-01-29	2005-09-21	Takeda Pharmaceutical	Proceso para producir una preparacion recubierta.
FR2858556B1 (fr) *	2003-08-06	2006-03-10	Galenix Innovations	Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP1738754B1 (de) *	2004-04-14	2015-07-15	Takeda Pharmaceutical Company Limited	Feste pharmazeutische zubereitung
WO2006011397A1 (ja) *	2004-07-27	2006-02-02	Kowa Company., Ltd.	糖尿病の予防または治療のための薬剤
KR20080007371A (ko)	2005-04-26	2008-01-18	다이닛본 스미토모 세이야꾸 가부시끼가이샤	비구아니드 화합물 함유 과립성 제제
MY149306A (en) *	2005-12-22	2013-08-30	Takeda Pharmaceutical	Solid preparation containing an insulin sensitizer
FR2896159B1 (fr)	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
JP4893750B2 (ja)	2006-12-26	2012-03-07	富士通株式会社	データ圧縮装置およびデータ復元装置
GEP20125410B (en)	2007-02-01	2012-02-27	Takeda Pharmaceutical	Solid preparation comprising alogliptin and pioglitazone
DK2120878T3 (da)	2007-02-09	2014-11-03	Alphapharm Pty Ltd	Doseringsform indeholdende to aktive farmaceutiske ingredienser i forskellige fysiske former
TR200803177A2 (tr) *	2008-05-06	2009-11-23	Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş.	Antihiperglisemik etkili metformîn - pioglitazon formülasyonu.
PE20151924A1 (es)	2008-08-12	2016-01-13	Zinfandel Pharmaceuticals Inc	Metodo de identificacion de factores de riesgo de la enfermedad
US8846315B2 (en)	2008-08-12	2014-09-30	Zinfandel Pharmaceuticals, Inc.	Disease risk factors and methods of use
FR2951945B1 (fr) *	2009-11-05	2013-08-09	Sanofi Aventis	Composition pharmaceutique
EP2498758B1 (de) *	2009-11-13	2018-07-25	AstraZeneca AB	Zweischichtige tablettenformulierungen
EP2441442A1 (de)	2010-10-08	2012-04-18	LEK Pharmaceuticals d.d.	Pharmazeutische Zusammensetzung mit einem Thiazolidindion
US9480663B2 (en)	2011-01-07	2016-11-01	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
US11759441B2 (en)	2011-01-07	2023-09-19	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
US11974971B2 (en)	2011-01-07	2024-05-07	Anji Pharmaceuticals Inc.	Compositions and methods for treating metabolic disorders
WO2013103384A1 (en)	2012-01-06	2013-07-11	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
CN103597071A (zh)	2011-01-07	2014-02-19	埃尔舍利克斯治疗公司	基于化学感应受体配体的治疗
US9211263B2 (en)	2012-01-06	2015-12-15	Elcelyx Therapeutics, Inc.	Compositions and methods of treating metabolic disorders
US8796338B2 (en)	2011-01-07	2014-08-05	Elcelyx Therapeutics, Inc	Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en)	2011-01-07	2017-02-21	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
EA201391017A1 (ru)	2011-01-10	2014-04-30	Зинфандел Фармасьютикалз, Инк.	Способы и готовые лекарственные формы для лечения болезни альцгеймера
EP2800562A2 (de)	2012-01-06	2014-11-12	Elcelyx Therapeutics, Inc.	Zusammensetzungen und verfahren zur behandlung von stoffwechselstörungen
CN108451923A (zh) *	2018-05-31	2018-08-28	常州兰陵制药有限公司	盐酸二甲双胍速释胶囊及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4613596Y1 (de) *	1969-06-02	1971-05-14
DE2347531A1 (de) *	1973-09-21	1975-04-30	Hoechst Ag	Arzneizubereitungen zur oralen diabetes-behandlung
ES2137915T3 (es) *	1987-09-04	2000-01-01	Beecham Group Plc	Derivados de tiazolidindiona sustituida.
US4999226A (en) *	1988-06-01	1991-03-12	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
JPH0553521A (ja)	1991-08-28	1993-03-05	Mitsubishi Electric Corp	オートトラツキング型ｃｒｔデイスプレイモニタ
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
IT1255522B (it)	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en) *	1993-09-21	2001-02-06	Jagotec Ag	Pharmaceutical tablet capable of liberating one or more drugs at different release rates
TW438587B (en) *	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
DE19539361A1 (de) *	1995-10-23	1997-04-24	Basf Ag	Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
GB2350319B (en)	1996-06-14	2001-01-10	Rue De Int Ltd	Security printed device
TW522014B (en)	1997-02-07	2003-03-01	Sepracor Inc	Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
DE122007000054I1 (de) *	1997-06-18	2007-12-13	Smithkline Beecham Plc	Behandlung der Diabetes mit Thiazolidindione und metformin
US20020004515A1 (en) *	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
GB9715295D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
JP4523153B2 (ja)	1998-03-19	2010-08-11	ブリストル−マイヤーズスクイブカンパニー	易溶性薬物の二層性放出制御送達システムおよび方法
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets
US20040102486A1 (en) *	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
US20040081697A1 (en) *	1998-11-12	2004-04-29	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
PT1131070E (pt)	1998-11-12	2008-11-19	Smithkline Beecham Plc	Composição farmacêutica para libertação modificada de um sensibilizador à insulina e de outro agente antidiabético
GB9824893D0 (en)	1998-11-12	1999-01-06	Smithkline Beckman Corp	Novel method of treatment
AR023700A1 (es)	1998-11-12	2002-09-04	Smithkline Beecham Plc	Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
EP1231917A2 (de)	1999-11-16	2002-08-21	Smithkline Beecham Plc	Pharmazeutische zusammensetzung enthaltend ein thiazolidinedion-metformin hydrochlorid
US6461639B2 (en) *	2000-05-01	2002-10-08	Aeropharm Technology, Inc.	Core formulation
US6780432B1 (en) *	2000-05-01	2004-08-24	Aeropharm Technology, Inc.	Core formulation
US6524621B2 (en) *	2000-05-01	2003-02-25	Aeropharm Technology Inc.	Core formulation
US6296874B1 (en) *	2000-05-01	2001-10-02	Aeropharm Technology Incorporated	Core formulation comprising troglitazone and abiguanide
US6403121B1 (en) *	2000-05-01	2002-06-11	Aeropharm Technology Incorporated	Core formulation
US6451342B2 (en) *	2000-05-01	2002-09-17	Aeropharm Technology Incorporated	Core formulation comprised of troglitazone and a biguanide
GB0318824D0 (en) *	2003-08-11	2003-09-10	Glaxo Group Ltd	Novel composition

2000
- 2000-11-15 MY MYPI20005360A patent/MY125516A/en unknown
- 2000-11-15 AR ARP000106019A patent/AR030920A1/es active IP Right Grant
- 2000-11-16 HU HU0204122A patent/HU229960B1/hu unknown
- 2000-11-16 OA OA1200200145A patent/OA12513A/en unknown
- 2000-11-16 DZ DZ003251A patent/DZ3251A1/fr active
- 2000-11-16 PE PE2000001226A patent/PE20011011A1/es not_active Application Discontinuation
- 2000-11-16 KR KR1020027006271A patent/KR100760063B1/ko active IP Right Grant
- 2000-11-16 EP EP00976156A patent/EP1231918B1/de not_active Expired - Lifetime
- 2000-11-16 RS YUP-388/02A patent/RS51343B/sr unknown
- 2000-11-16 DK DK00976156T patent/DK1231918T3/da active
- 2000-11-16 EP EP04078538A patent/EP1520581A1/de not_active Withdrawn
- 2000-11-16 ME MEP-2008-340A patent/ME00318B/me unknown
- 2000-11-16 SI SI200030697T patent/SI1231918T1/xx unknown
- 2000-11-16 NZ NZ518946A patent/NZ518946A/en not_active IP Right Cessation
- 2000-11-16 EP EP07120386A patent/EP1913945A3/de not_active Withdrawn
- 2000-11-16 AT AT00976156T patent/ATE292466T1/de active
- 2000-11-16 JP JP2001537934A patent/JP4865975B2/ja not_active Expired - Lifetime
- 2000-11-16 CZ CZ20021679A patent/CZ302500B6/cs not_active IP Right Cessation
- 2000-11-16 UA UA2002064826A patent/UA73150C2/uk unknown
- 2000-11-16 CA CA002388846A patent/CA2388846A1/en not_active Abandoned
- 2000-11-16 MX MXPA02005005A patent/MXPA02005005A/es active IP Right Grant
- 2000-11-16 UY UY26439A patent/UY26439A1/es not_active IP Right Cessation
- 2000-11-16 ES ES00976156T patent/ES2240199T3/es not_active Expired - Lifetime
- 2000-11-16 CN CNB008178224A patent/CN1222290C/zh not_active Expired - Lifetime
- 2000-11-16 WO PCT/GB2000/004368 patent/WO2001035941A2/en active Application Filing
- 2000-11-16 IL IL14961800A patent/IL149618A0/xx unknown
- 2000-11-16 DE DE60019329T patent/DE60019329T2/de not_active Expired - Lifetime
- 2000-11-16 BR BR0015605-1A patent/BR0015605A/pt not_active Application Discontinuation
- 2000-11-16 EA EA200200571A patent/EA004878B1/ru not_active IP Right Cessation
- 2000-11-16 AP APAP/P/2002/002505A patent/AP1389A/en active
- 2000-11-16 PL PL355331A patent/PL200943B1/pl unknown
- 2000-11-16 PT PT00976156T patent/PT1231918E/pt unknown
- 2000-11-16 SK SK679-2002A patent/SK286985B6/sk not_active IP Right Cessation
- 2000-11-16 AU AU14040/01A patent/AU775654B2/en not_active Expired
- 2000-11-20 CO CO00088045A patent/CO5300392A1/es not_active Application Discontinuation
- 2000-12-04 TW TW089125730A patent/TWI240626B/zh not_active IP Right Cessation
2002
- 2002-05-13 IL IL149618A patent/IL149618A/en unknown
- 2002-05-14 HR HR20020416A patent/HRP20020416B1/xx not_active IP Right Cessation
- 2002-05-15 MA MA26640A patent/MA25567A1/fr unknown
- 2002-05-15 NO NO20022334A patent/NO329926B1/no not_active IP Right Cessation
- 2002-05-29 BG BG106747A patent/BG65616B1/bg unknown
2003
- 2003-01-29 HK HK03100745.5A patent/HK1049788B/zh not_active IP Right Cessation
2004
- 2004-11-04 AU AU2004226955A patent/AU2004226955B2/en not_active Expired
2006
- 2006-12-05 AR ARP060105370A patent/AR057970A2/es active IP Right Grant
2007
- 2007-07-18 US US11/779,546 patent/US8236345B2/en not_active Expired - Fee Related
2008
- 2008-03-17 IL IL190220A patent/IL190220A0/en unknown
- 2008-08-18 AU AU2008207375A patent/AU2008207375A1/en not_active Abandoned
2011
- 2011-08-11 JP JP2011175883A patent/JP5282130B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2004226955B2 (en)	2008-08-28
HK1049788B (zh)	2005-11-04
EA200200571A1 (ru)	2002-12-26
NO329926B1 (no)	2011-01-24
CA2388846A1 (en)	2001-05-25
IL149618A (en)	2008-07-08
HRP20020416A2 (en)	2004-08-31
BG106747A (en)	2003-01-31
EP1913945A3 (de)	2008-04-30
PL355331A1 (en)	2004-04-19
IL149618A0 (en)	2002-12-01
TWI240626B (en)	2005-10-01
SK286985B6 (sk)	2009-08-06
CZ302500B6 (cs)	2011-06-22
JP5282130B2 (ja)	2013-09-04
EP1231918A2 (de)	2002-08-21
AR030920A1 (es)	2003-09-03
KR100760063B1 (ko)	2007-09-18
EA004878B1 (ru)	2004-08-26
PT1231918E (pt)	2005-08-31
PL200943B1 (pl)	2009-02-27
NZ518946A (en)	2003-10-31
DE60019329T2 (de)	2006-03-09
EP1913945A2 (de)	2008-04-23
AU1404001A (en)	2001-05-30
EP1520581A1 (de)	2005-04-06
US20070275054A1 (en)	2007-11-29
PE20011011A1 (es)	2001-10-28
MXPA02005005A (es)	2003-10-14
DE60019329D1 (de)	2005-05-12
MY125516A (en)	2006-08-30
UY26439A1 (es)	2001-07-31
SK6792002A3 (en)	2002-09-10
IL190220A0 (en)	2008-11-03
HK1049788A1 (en)	2003-05-30
JP4865975B2 (ja)	2012-02-01
UA73150C2 (uk)	2005-06-15
EP1231918B1 (de)	2005-04-06
CO5300392A1 (es)	2003-07-31
DK1231918T3 (da)	2005-08-01
HRP20020416B1 (en)	2011-04-30
MEP34008A (en)	2011-02-10
RS51343B (sr)	2011-02-28
US8236345B2 (en)	2012-08-07
KR20030019300A (ko)	2003-03-06
CN1222290C (zh)	2005-10-12
JP2011252007A (ja)	2011-12-15
BG65616B1 (bg)	2009-03-31
AR057970A2 (es)	2007-12-26
OA12513A (en)	2006-05-29
NO20022334D0 (no)	2002-05-15
AU2008207375A1 (en)	2008-09-11
MA25567A1 (fr)	2002-10-01
HUP0204122A3 (en)	2006-01-30
AU2004226955A1 (en)	2004-12-02
HUP0204122A2 (hu)	2003-03-28
ES2240199T3 (es)	2005-10-16
BR0015605A (pt)	2002-07-09
JP2003514012A (ja)	2003-04-15
DZ3251A1 (fr)	2001-05-25
AP1389A (en)	2005-04-14
WO2001035941A8 (en)	2002-08-29
YU38802A (sh)	2005-03-15
WO2001035941A3 (en)	2002-05-23
CN1414852A (zh)	2003-04-30
SI1231918T1 (en)	2005-08-31
ME00318B (me)	2011-05-10
WO2001035941A2 (en)	2001-05-25
AP2002002505A0 (en)	2002-06-30
AU775654B2 (en)	2004-08-12
NO20022334L (no)	2002-07-09
HU229960B1 (hu)	2015-03-30

Publication	Publication Date	Title
ATE292466T1 (de)	2005-04-15	Neue zusammensetzung auf basis von einem thiazolidindion und metformin und verwendung
ATE218850T1 (de)	2002-06-15	Zusammensetzungen auf basis von sphingomyelinase und ihre verwendung
ATE204302T1 (de)	2001-09-15	Eine neue zusammensetzung, ihre herstellung und verwendung
ATE261935T1 (de)	2004-04-15	Neue metformin salze und verfahren
FI972312L (fi)	1997-12-30	Uusia siiliperäisiä polypeptidejä
DE59503881D1 (de)	1998-11-12	Heterospiroverbindungen und ihre verwendung als elektrolumineszenzmaterialien
DE60027479D1 (de)	2006-05-24	Harzstruktur und ihre verwendung
DE69735455D1 (de)	2006-05-11	Flächengebilde mit hervorragenden Teilen aus der Oberfläche, zur Erzeugung von Distanz, Griffverbesserung, Abfuhrelementen und dergleichen
DE60000958D1 (de)	2003-01-23	Epoxidharzzusammensetzung und ihre Verwendung
DE69720389D1 (de)	2003-05-08	Zementzusammensetzungen und ihre Verwendung
ATE298337T1 (de)	2005-07-15	Neue verwendung sowie neue n-azabicycloamid- verbindungen
DE50010613D1 (de)	2005-07-28	Polyurethan-zusammensetzungen auf der basis von polyester-polyether-copolymeren
DE69516036D1 (de)	2000-05-11	Aromatische Verbindungen und ihre Verwendung in der Parfümerie
DE69417801D1 (de)	1999-05-20	Schalteranordnung und ihre Verwendung bei einer Stableuchte
ATE298508T1 (de)	2005-07-15	Neue verwendung von antifungalen, antibakteriellen und/oder antiviralen zusammensetzungen
DE59709806D1 (de)	2003-05-15	Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
DE69937516D1 (de)	2007-12-27	Nicht-linearer Widerstand
DE60027927D1 (de)	2006-06-14	Harzstruktur und ihre verwendung
DE69536102D1 (de)	2010-10-21	Neue streptogramine
DE69806419D1 (de)	2002-08-14	Harzzusammensetzung und ihre Verwendung
DE69824201D1 (de)	2004-07-01	Neue 9a-azalide
DE69917261D1 (de)	2004-06-17	Photoinitiatoren und ihre verwendungen
ATE221853T1 (de)	2002-08-15	Containerbrücke
DE59808412D1 (de)	2003-06-26	Feststoff-Zusammensetzung auf Basis von Tonmineralien und deren Verwendung
DE60030366D1 (de)	2006-10-12	Flexible Harzzusammensetzung und ihre Verwendung

Legal Events

Date	Code	Title	Description
2005-12-15	UEP	Publication of translation of european patent specification	Ref document number: 1231918 Country of ref document: EP

Date

Code

Title

Description

2005-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1231918

Country of ref document: EP